Magnificent Ventures is a venture capital firm focused on transformative technologies, with a particular emphasis on human health, longevity, and potential. Its investment activity includes the technical domain of CRISPR gene editing, positioning it within the biotechnology and healthcare sectors.
The firm's operational philosophy integrates social impact into its financial structure. It donates 80 percent of its carried interest profits to the Root Cause Project and WHEN Justice. This model directs financial gains from investments toward organizations working on systemic change.
Magnificent Ventures describes its mission as creating wealth for a greater purpose, with a stated focus on action, purpose, and foundational impact. The firm operates within the venture capital, healthcare, biotechnology, and social impact verticals.
